Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
Month of birth is not a definite risk factor for multiple sclerosis.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Evaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences.
[Inflammatory and autoimmune reactions in different forms of nervous system functioning disorders].
Microenvironmental Regulation of Oligodendrocyte Replacement and Remyelination in Spinal Cord Injury.
Efficacy of Tryptophan Immunoadsorption Plasmapheresis for Neuromyelitis Optica in Two Cases.
The immunomodulatory oligodendrocyte.
Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.
Orthopaedic Management of Spasticity.
Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Optic nerve head component responses of the multifocal electroretinogram in MS.
Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale.
Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway.
Correction: Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
[Low back pain: atypical presentation of multiple sclerosis.]
Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Tai Chi Chuan in Medicine and Health Promotion.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Biomarkers for MS: Unpuzzling the progressive multiple sclerosis puzzle.
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Pages
« first
‹ previous
…
556
557
558
559
560
561
562
563
564
…
next ›
last »